Carbonic Anhydrase I Is Recognized by an SOD1 Antibody upon Biotinylation of Human Spinal Cord Extracts

We recently reported the presence of a novel 32 kDa protein immunoreactive to a copper, zinc superoxide dismutase (SOD1) antibody within the spinal cord of patients with amyotrophic lateral sclerosis (ALS). This unique protein species was generated by biotinylation of spinal cord tissue extracts to detect conformational changes of SOD1 specific to ALS patients. To further characterize this protein, we enriched the protein by column chromatography and determined its protein identity by mass spectrometry. The protein that gave rise to the 32 kDa species upon biotinylation was identified as carbonic anhydrase I (CA I). Biotinylation of CA I from ALS spinal cord resulted in the generation of a novel epitope recognized by the SOD1 antibody. This epitope could also be generated by biotinylation of extracts from cultured cells expressing human CA I. Peptide competition assays identified the amino acid sequence in carbonic anhydrase I responsible for binding the SOD1 antibody. We conclude that chemical modifications used to identify pathogenic protein conformations can lead to the identification of unanticipated proteins that may participate in disease pathogenesis.

[1]  L. Piedrafita,et al.  Neurotoxic Species of Misfolded SOD1G93A Recognized by Antibodies Against the P2X4 Subunit of the ATP Receptor Accumulate in Damaged Neurons of Transgenic Animal Models of Amyotrophic Lateral Sclerosis , 2010, Journal of neuropathology and experimental neurology.

[2]  A. Al-Chalabi,et al.  Genetic studies of amyotrophic lateral sclerosis: Controversies and perspectives , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[3]  I. Carrico Chemoselective modification of proteins: hitting the target. , 2008, Chemical Society reviews.

[4]  Jan Albrecht,et al.  Regulation of pH in the mammalian central nervous system under normal and pathological conditions: Facts and hypotheses , 2008, Neurochemistry International.

[5]  R. Bowser,et al.  Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis , 2007, Proceedings of the National Academy of Sciences.

[6]  P. Eaton Protein thiol oxidation in health and disease: techniques for measuring disulfides and related modifications in complex protein mixtures. , 2006, Free radical biology & medicine.

[7]  M. Strong,et al.  The basic aspects of therapeutics in amyotrophic lateral sclerosis. , 2003, Pharmacology & therapeutics.

[8]  J. B. Jones,et al.  Chemical modification of enzymes for enhanced functionality. , 1999, Current opinion in biotechnology.

[9]  J. Valmier,et al.  Early postnatal muscle contractile activity regulates the carbonic anhydrase phenotype of proprioceptive neurons in young and mature mice: Evidence for a critical period in development , 1996, Neuroscience.

[10]  D. Borchelt,et al.  Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  W. Miller,et al.  A time-efficient, linear-space local similarity algorithm , 1991 .

[12]  K. Watanabe,et al.  Chemical modification of gamma-carboxyglutamic acid residues in prothrombin elicits a conformation similar to that of abnormal (des-gamma-carboxy)prothrombin. , 1990, Journal of biochemistry.

[13]  D. Riley,et al.  Ultrastructural cytochemical localization of carbonic anhydrase activity in rat peripheral sensory and motor nerves, dorsal root ganglia and dorsal column nuclei , 1984, Neuroscience.

[14]  M. Schwartz,et al.  Carbonic anhydrase III in neuromuscular disorders , 1983, Journal of the Neurological Sciences.

[15]  A. Leitner,et al.  Applications of chemical tagging approaches in combination with 2DE and mass spectrometry. , 2009, Methods in molecular biology.

[16]  C. Ortega-Camarillo,et al.  Reactive oxygen species (ROS) induce chemical and structural changes on human insulin in vitro, including alterations in its immunoreactivity. , 2005, Frontiers in bioscience : a journal and virtual library.